close
close

Connect Biopharma to participate in Cantor Fitzgerald Global Healthcare Conference 2024





Connect Biopharma Holdings (Nasdaq:CNTB)a global clinical-stage biopharmaceutical company, has announced its participation in the Cantor Fitzgerald Global Healthcare Conference 2024The event will take place from 17 to 19 September in New York, NY. The management team of Connect Biopharma will give a corporate presentation on September 19, 2024, 9:10 a.m. ET at the InterContinental New York Barclay Hotel.

The presentation will be accessible via webcast and the management team will also conduct one-on-one meetings during the conference. Investors interested in arranging meetings should contact their Cantor Fitzgerald representative. Connect Biopharma will provide links to access the corporate presentation in the Investors section of its website under Presentations and Events.

Connect Biopharma Holdings (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company, announced its participation Conference Sanitaria Globale by Cantor Fitzgerald 2024. The event will take place through 17 to 19 September a New York, NY. The team managed by Connect Biopharma is facilitating an international intervention September 19, 2024, all 9:10 a.m. ET Press at the InterContinental New York Barclay Hotel.

The presentation will be accessible via webcast and the team will be holding one-on-one meetings during the conference. Interested investors interested in programs should contact the responsible Cantor Fitzgerald representative. Connect Biopharma has set up colleagues to attend the presentation in the online section “Lorore Investitori”, under Presentations and Events.

Connect Biopharma Holdings (Nasdaq: CNTB), a global biopharmaceutical company and clinical hospital, announced their participation on April 1 Conference Global de Salud de Cantor Fitzgerald 2024. The event is about to happen 17 to 19 September in New York, NY. The management team of Connect Biopharma made a presentation of the company September 19, 2024, at 9:10 a.m. ET at the InterContinental New York Barclay Hotel.

The presentation will be accessible via webcast, and the leadership team will also host one-on-one meetings during the conference. Investors interested in program meetings should contact their Cantor Fitzgerald representative. Connect Biopharma will provide access to the Company's presentation in the Investors section of its website under “Presentations and Events.”

Connect Biopharma Holdings (Nasdaq:CNTB), 2024 – 2024 – 2024 – 2024에 참여한다고 발표했습니다. 이 행사는 9 Oct 17 – 19 Oct 뉴욕에서 개최됩니다. Connect Biopharma is an online portal September 9, 2024, September 19, 10 a.m. ET에 인터컨티넨탈 뉴욕 바클리 호텔에서 회사 발표를 진행할 예정입니다.

1:1 . The film was created by Cantor Fitzgerald and his son Cantor Fitzgerald. Connect Biopharma is one of the leading providers of biopharmaceutical products 할 입니다.

Connect Biopharma Holdings (Nasdaq: CNTB), a global biopharmaceutical company in Phase Clinique, announced its participation in this year Mondiale Conference on the Santé de Cantor Fitzgerald 2024. The event takes place 17 to 19 September to New York, NY. The Connect Biopharma team conducted a company presentation September 19, 2024 at 9:10 a.m. ET at the InterContinental New York Barclay Hotel.

The presentation is accessible via webcast and the team that takes charge of the organizer is also in charge of conducting individual meetings on the occasion of the conference. The investors who decided to reunite contacted their representative from Cantor Fitzgerald Connect Biopharma with Liens to access the company presentation in the “Investisseur” section of the presentations and events website.

Connect Biopharma Holdings (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company, announced its participation in the Cantor Fitzgerald Global Healthcare Conference 2024 The event will take place from 17 to 19 September in New York, NY. The management team of Connect Biopharma will be September 19, 2024 at 9:10 a.m. ET give a corporate presentation at the InterContinental New York Barclay Hotel.

The presentation will be accessible via webcast, and the management team will also conduct in-person meetings during the conference. Investors wishing to schedule meetings should contact their Cantor Fitzgerald representative. Connect Biopharma will provide links to access the company presentation in the investor section of its website under Presentations & Events.











SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect” or the “Company”), a U.S.-based global clinical-stage biopharmaceutical company committed to improving the lives of patients with inflammatory diseases, today announced that Connect Biopharma's management team will participate in the 2024 Cantor Fitzgerald Global Healthcare Conference taking place on September 17 in New York, NY.th – 19 SeptemberthDetails of the presentation can be found below.

Format: Company presentation
Date and time: September 19, 2024, 9:10 a.m. ET
Location: InterContinental New York Barclay Hotel
Link to the webcast:

Connect Biopharma's management team will be holding one-on-one meetings during the conference. Interested investors should contact their Cantor Fitzgerald representative to arrange a meeting. Links to access corporate presentations for select events will be posted on the Connect Biopharma website on the Presentations and Events page in the Investors section, when available.

About Connect Biopharma Holdings Limited

Connect Biopharma is a global clinical-stage biopharmaceutical company developing innovative therapies to treat inflammatory diseases with the goal of improving the lives of millions of people around the world. The Company's lead product candidate, Rademikibart (formerly known as CBP-201), is an antibody targeting the interleukin-4 receptor alpha (IL-4Rα) and has demonstrated activity in both atopic dermatitis and asthma. The Company's second product candidate, Icanbelimod (formerly known as CBP-307), is a modulator of S1P1 T-cell receptors and has demonstrated activity in ulcerative colitis. For more information, please visit:

CONTACT FOR INVESTORS:

David Szekeres

president

[email protected]









Frequently Asked Questions



When and where will Connect Biopharma (CNTB) present at the Cantor Fitzgerald Global Healthcare Conference 2024?

Connect Biopharma (CNTB) will present on September 19, 2024 at 9:10 a.m. ET at the InterContinental New York Barclay Hotel during the Cantor Fitzgerald Global Healthcare Conference 2024.


How can investors access Connect Biopharma (CNTB)’s presentation at the Cantor Fitzgerald conference?

Investors may access Connect Biopharma’s (CNTB) presentation via webcast via the link or via the Company’s website on the “Presentations and Events” page in the “Investors” section.


What are the dates for the Cantor Fitzgerald Global Healthcare Conference 2024 attended by Connect Biopharma (CNTB)?

The Cantor Fitzgerald Global Healthcare Conference 2024 will be held September 17-19, 2024, in New York, NY.


Will Connect Biopharma (CNTB) be available for one-on-one meetings during the Cantor Fitzgerald conference?

Yes, Connect Biopharma's (CNTB) management team will be holding one-on-one meetings during the conference. Interested investors should contact their Cantor Fitzgerald representative to request meetings.





You may also like...